Inogen (NASDAQ:INGN) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.15, beating the consensus estimate of $-0.25 by $0.10 per share. Revenue came in at $81.7M, missing the estimate of $82.0M.
Inogen's stock moved following the earnings release. The stock currently trades at $5.59 with a market capitalization of $190.8M.